Ventas VTR OM&R — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ventas in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Ventas’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ventas's om&r — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ventas's OM&R — revenue?
- Ventas (VTR) reported OM&R — revenue of $230.9M in Q1 2026.
- How has Ventas's OM&R — revenue changed year-over-year?
- Ventas's OM&R — revenue increased by 4.0% year-over-year, from $222M to $230.9M.
- What is the long-term trend for Ventas's OM&R — revenue?
- Over 4 years (2021 to 2025), Ventas's OM&R — revenue has grown at a 2.8% compound annual growth rate (CAGR), from $802.68M to $897.9M.
- What does OM&R — revenue mean?
- The total gross revenue generated by the Outpatient Medical and Research segment, primarily consisting of rental income from tenants. This is the top-line metric for the segment and represents the total market demand for the company's medical office and life science space. It is the starting point for calculating segment-level profitability.